Literature DB >> 28977590

Kisspeptin Stimulates Growth Hormone Release by Utilizing Neuropeptide Y Pathways and Is Dependent on the Presence of Ghrelin in the Ewe.

Chad D Foradori1, Brian K Whitlock2, Jay A Daniel3, Arthur D Zimmerman1, Melaney A Jones1, Casey C Read1, Barbara P Steele1, Jeremy T Smith4, Iain J Clarke5, Theodore H Elsasser6, Duane H Keisler7, James L Sartin1.   

Abstract

Although kisspeptin is the primary stimulator of gonadotropin-releasing hormone secretion and therefore the hypothalamic-pituitary-gonadal axis, recent findings suggest kisspeptin can also regulate additional neuroendocrine processes including release of growth hormone (GH). Here we show that central delivery of kisspeptin causes a robust rise in plasma GH in fasted but not fed sheep. Kisspeptin-induced GH secretion was similar in animals fasted for 24 hours and those fasted for 72 hours, suggesting that the factors involved in kisspeptin-induced GH secretion are responsive to loss of food availability and not the result of severe negative energy balance. Pretreatment with the neuropeptide Y (NPY) Y1 receptor antagonist, BIBO 3304, blocked the effects of kisspeptin-induced GH release, implicating NPY as an intermediary. Kisspeptin treatment induced c-Fos in NPY and GH-releasing hormone (GHRH) cells of the arcuate nucleus. The same kisspeptin treatment resulted in a reduction in c-Fos in somatostatin (SS) cells in the periventricular nucleus. Finally, blockade of systemic ghrelin release or antagonism of the ghrelin receptor eliminated or reduced the ability of kisspeptin to induce GH release, suggesting the presence of ghrelin is required for kisspeptin-induced GH release in fasted animals. Our findings support the hypothesis that during short-term fasting, systemic ghrelin concentrations and NPY expression in the arcuate nucleus rise. This permits kisspeptin activation of NPY cells. In turn, NPY stimulates GHRH cells and inhibits SS cells, resulting in GH release. We propose a mechanism by which kisspeptin conveys reproductive and hormone status onto the somatotropic axis, resulting in alterations in GH release.
Copyright © 2017 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28977590     DOI: 10.1210/en.2017-00303

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Metabolic actions of kisspeptin signaling: Effects on body weight, energy expenditure, and feeding.

Authors:  Alexandra D Hudson; Alexander S Kauffman
Journal:  Pharmacol Ther       Date:  2021-09-14       Impact factor: 12.310

2.  Changes of plasma concentration and gene expression of ghrelin and leptin in rats receiving kisspeptin and morphine.

Authors:  Homayoun Khazali; Fariba Mahmoud
Journal:  Vet Res Forum       Date:  2022-03-15       Impact factor: 0.950

3.  Creatinine as a Urinary Marker of the Purine Derivatives Excretion in Urine Spot Samples of Lambs Fed Peach Palm Meal.

Authors:  Taiala Cristina de Jesus Pereira; Mara Lúcia Albuquerque Pereira; Gleidson Giordano Pinto de Carvalho; Herymá Giovane de Oliveira Silva; Alana Batista Dos Santos; Douglas Dos Santos Pina; Leandro Borges Sousa
Journal:  Animals (Basel)       Date:  2022-05-06       Impact factor: 3.231

Review 4.  A Comparative Update on the Neuroendocrine Regulation of Growth Hormone in Vertebrates.

Authors:  Emilio J Vélez; Suraj Unniappan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-23       Impact factor: 5.555

5.  Does kisspeptin act as a neuropeptide or as an adipokine in obese people?

Authors:  Suzanne J Abbas; Fatimah S Abed; Iqbal H Dhefer
Journal:  J Taibah Univ Med Sci       Date:  2021-08-18

Review 6.  Metabolic Impact on the Hypothalamic Kisspeptin-Kiss1r Signaling Pathway.

Authors:  Fazal Wahab; Bibi Atika; Farhad Ullah; Muhammad Shahab; Rüdiger Behr
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-28       Impact factor: 5.555

7.  Evidence of Alternative Splicing as a Regulatory Mechanism for Kissr2 in Pejerrey Fish.

Authors:  Alejandro S Mechaly; M Oswaldo Tovar Bohórquez; Ariel E Mechaly; Eda Suku; María Rita Pérez; Alejandro Giorgetti; Guillermo Ortí; Jordi Viñas; Gustavo M Somoza
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-17       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.